MaurizioZangariMD

Clinical Trials

• Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy Start of enrollment: 1998 Jun 01

  Completed

  Phase 2

• Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2006 Apr 01

  Terminated

  Phase 2

• UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2005 Aug 01

  Completed

  Not Applicable

• Therapeutic Research in Multiple Myeloma Start of enrollment: 2003 Aug 01

  Completed

• UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Start of enrollment: 2008 Jul 01

  Active, not recruiting

  Phase 3

• Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy Start of enrollment: 2009 Mar 01

  Active, not recruiting

  Phase 2

• Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients Start of enrollment: 2009 Oct 01

  Terminated

  Phase 2

• Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2010 Jan 01

  Terminated

  Phase 2

• UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma Start of enrollment: 2010 Apr 01

  Completed

  Phase 3

• UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma Start of enrollment: 2013 Apr 01

  Completed

  Phase 2

• UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib Start of enrollment: 2015 Mar 01

  Withdrawn

  Phase 2

• UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus Start of enrollment: 2015 Mar 01

  Completed

  Phase 2

• Join now to see all